Breast cancer guidelines for Uganda (2nd Edition 2007)
MetadataShow full item record
Breast cancer in Uganda is the third commonest cancer in women coming only next to cancer of the cervix and Kaposi’s sarcoma. The incidence of breast cancer in Uganda has doubled from11: 100,000 in 1961 to 22:100,000 in 19951,2,. Many patients are often seen in late stages thus the outcome of treatment is mostly unsatisfactory. The present day knowledge of this disease does not have any effective primary prevention. It is thus imperative that efforts should be made to detect the disease in its early stages. Mammography has been found to be useful but it is not feasible for mass screening in Uganda, as there is a limited number of units accessible to the general public. Public education towards Breast Self Examination (BSE) should be propagated because it is practical and affordable
Showing items related by title, author, creator and subject.
Knowledge, attitudes and practices of breast cancer screening among rural women in Bubaare Sub-County, Rubanda District Nsenga, Marcella (Makerere University, 2018-08-30)Introduction: Breast cancer in women is a major public health burden and the most common cancer among women Worldwide. Though its incidence is greater in high income countries, in sharp contrast, mortality rates are greatest ...
Comparison of fine needle aspiration cytology and fine needle sampling without aspiration in the diagnosis of palpable breast lumps in mulago hospital. Alema, Onira Nelson (2009-07)INTRODUCTION: Open biopsy of the breast used to be the main traditional method of diagnosis of breast lumps. This was traumatic and done under anaesthesia. In 1021, fine needle biopsy (FNB) was introduced by Guthrie in ...
BRCA1 and BRCA2 mutations in selected exons in breast cancer patients attending Mulago Hospital, Uganda Nankya, Prossie Lindah (Makerere University, 2017-02)Breast cancer 1 (BRCA1) and Breast cancer 2 (BRCA2), mutation recognition is crucial for cancer risk assessment, identification of suitable breast cancer treatments, and personalised breast cancer prophylaxis in mutation ...